Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of alpha amino acid esters. Its chemical formula is C18H15NO3S and it has a molecular weight of approximately 325.38 g/mol. The structure features a thiazolo[2,3-a]isoindole core with an oxo group at position 5 and a phenyl substituent at position 9b; the carboxylic acid moiety is present as its methyl ester derivative. It is classified as an experimental drug and has not been approved for any medical use or entered clinical trials beyond preclinical/experimental stages. There are no known indications or established mechanisms of action for this molecule in humans or animals based on current data sources.[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER.